Maureen G Caligiuri

Title: Maureen G Caligiuri: Innovator in Ubiquitin Ligases

Introduction

Maureen G Caligiuri is a prominent inventor based in Huntington, NY (US). She has made significant contributions to the field of molecular biology, particularly in the study of ubiquitin ligases. With a total of 2 patents, her work has implications for understanding cell cycle regulation in eukaryotic cells.

Latest Patents

Caligiuri's latest patents focus on the discovery of ubiquitin ligases in eukaryotic cells. These proteins, collectively referred to as "pub" proteins, include h-pub1, h-pub2, and s-pub1. Her research indicates that pub1 proteins play a crucial role in the ubiquitination of the mitotic activating tyrosine phosphatase cdc25. This process is essential for regulating the progression of cell proliferation by activating cyclin-dependent kinase complexes. Disruption of s-pub1 leads to elevated levels of cdc25 protein, which increases the activity of tyrosine kinases, wee1 and mik1, necessary for cell-cycle arrest. The loss of wee1 function in cells with a disrupted s-pub1 gene results in a lethal premature entry into mitosis, a phenotype that can be rescued by the loss of cdc25 function.

Career Highlights

Caligiuri is affiliated with Cold Spring Harbor Laboratory, where she conducts her research. Her work has garnered attention for its potential applications in cancer research and cell biology.

Collaborations

Some of her notable coworkers include David H Beach and Bradley Nefsky, who have contributed to her research endeavors.

Conclusion

Maureen G Caligiuri's innovative work in the field of ubiquitin ligases highlights her significant role in advancing our understanding of cell cycle regulation. Her contributions continue to impact the scientific community and pave the way for future research.